Exploring the associations between polypharmacy and COVID-19-related hospitalisations and deaths: a population-based cohort study among older adults in Quebec, Canada.

Caroline SiroisVéronique BoiteauYohann ChiuRodica GilcaMarc Simard

Published in: BMJ open (2022)

Polypharmacy was significantly associated with the risk of hospitalisations and deaths related to COVID-19 in this cohort of older adults. Polypharmacy may represent a marker of vulnerability, especially for younger groups of older adults.

Keyphrases

coronavirus disease
sars cov
physical activity
adverse drug
climate change
emergency department
drug induced